181 related articles for article (PubMed ID: 160840)
1. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
2. [A iatrogenic disease... subacute myelo-optico-neuropathy].
Degos CF; Thomas-Lamotte PJ
Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
[No Abstract] [Full Text] [Related]
3. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
[No Abstract] [Full Text] [Related]
4. Sub-acute myelo-optico neuropathy (a case report).
Mathew R; Gupta PS
J Assoc Physicians India; 1978 Jun; 26(6):547-8. PubMed ID: 152755
[No Abstract] [Full Text] [Related]
5. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
Bron HL; Korten JJ; Pinckers AJ; Majoor CL
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
[No Abstract] [Full Text] [Related]
6. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
[No Abstract] [Full Text] [Related]
7. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
8. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
Shigematsu I
Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
[No Abstract] [Full Text] [Related]
9. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
10. [Subacute myelo-optico neuropathy (author's transl)].
Heilig P; Thaler A
Klin Monbl Augenheilkd; 1974 Mar; 164(3):386-8. PubMed ID: 4277280
[No Abstract] [Full Text] [Related]
11. [Case of subacute myelo-optico-neuropathy].
Mackiewicz J; Wendorff J
Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
[TBL] [Abstract][Full Text] [Related]
12. [Subacute myelo-optic neuropathy--toxic reaction or viral disease?].
Dimov D
Lijec Vjesn; 1972 Jul; 94(7):363-6. PubMed ID: 4266549
[No Abstract] [Full Text] [Related]
13. Subacute myelo-optico-neuropathy (SMON).
Nelson E
Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
[No Abstract] [Full Text] [Related]
14. Subacute myelo-optic neuropathy. A toxic or a viral etiology?
Otte G; De Coster W; Thiery E; De Reuck J; Vander eecken H
Acta Neurol Belg; 1976; 76(5-6):331-4. PubMed ID: 137650
[TBL] [Abstract][Full Text] [Related]
15. Subacute myelo-optic neuropathy in Australia.
Selby G
Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
[No Abstract] [Full Text] [Related]
16. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
17. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
Nakae K; Yamamoto S; Shigematsu I; Kono R
Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
[No Abstract] [Full Text] [Related]
18. [Neurotoxicity of chinoform].
Iwashita H
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
[No Abstract] [Full Text] [Related]
19. [Neurotoxic symptoms following clioquinol (Enterovioform)].
Pannekoek JH
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
[No Abstract] [Full Text] [Related]
20. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
